Pharmacy Times December 10, 2024
Aislinn Antrim, Assistant Managing Editor

Key Takeaways

  • ASHP is engaging with Congress in a bipartisan manner to address health-system pharmacy issues amid a polarized political environment.
  • Scope expansion and pharmacist reimbursement are progressing, with many states allowing pharmacists to prescribe medications and enroll as providers.
  • The shift toward a standard of care regulatory model aims to broaden pharmacy practice, emphasizing accountability and oversight.
  • Challenges in the 340B Drug Pricing Program and site-neutral payments pose financial risks to institutions, requiring advocacy and collaboration.
  • PBM reform is ongoing, with FTC findings highlighting anticompetitive practices and legislative proposals addressing transparency and pricing.

The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists’ value within the health care system.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Healthcare and Life Sciences: Key Insights and Considerations for Stakeholders in 2025
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
FDA approves 1st monotherapy drug for treatment-resistant depression

Share This Article